Endpoints News 2025-12-02 ARCH, Parker Institute build next big oncology bet with suite of programs and startup acquisition
Endpoints News 2025-12-02 Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug
Endpoints News 2025-12-02 As approval date looms, Cytokinetics gears up for David-and-Goliath battle with Bristol Myers
Endpoints News 2025-12-02 Imvax shares Phase 2b data for glioblastoma treatment, plans to meet with FDA
Endpoints News 2025-12-01 Janux’s prostate cancer immunotherapy’s response rate drops, according to new early-stage data
Endpoints News 2025-12-01 Belite Bio aims for first approval of Stargardt disease treatment with Phase 3 success
Endpoints News 2025-12-01 Angelini, European Investment Bank join forces; Radiopharma startup raises $40M